1.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: NIMH Protocol IDs: R01 MH071580, DATR A3-NSS, NCT00352885
|
|
2.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 40 to 69 Sponsor: Other Protocol IDs: STAF001982HU, NCT00906269
|
|
3.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-09-14B, NCT00984269
|
|
4.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AAO-101, NCT00466388
|
|
5.
|
Phase: Phase IV Type: Behavioral study, Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: #5996, NCT01191580
|
|
6.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-038, NCT01200355
|
|
7.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: APC-10U1101, NCT01283906
|
|
8.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 110032, NCT01385488
|
|
9.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NA_00041916, NCT01416025
|
|
10.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Mann-Cohen Version 2, NCT01459666
|
|
11.
|
Phase: Phase IV Type: Supportive care Status: Active Age: Not specified Sponsor: Other Protocol IDs: 09-005037, NCT01615653
|
|
12.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 110806, NCT01625455
|
|
13.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 30 to 90 Sponsor: Other Protocol IDs: UPCC 15810, NCT01661166
|
|
14.
|
Phase: Phase IV Type: Health services research, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 240293, NCT01698177
|
|
15.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VESI-12J03, NCT01777217
|
|
16.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PRO11020226, NCT01781299
|
|
17.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 30 and under Sponsor: Other Protocol IDs: BMT 0703, NCT00179855
|
|
18.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 months to 21 years Sponsor: Other Protocol IDs: #1R01FD003410-01, R01 FD003410-01-A1, NCT00999713
|
|
19.
|
Phase: Phase III, Phase II Type: Behavioral study, Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: BRS0008, K07CA132916-01A1, 25740, NCT01011218
|
|
20.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 609, U01HL069294, BMT CTN 0801, U01HL069294-06, NCT01106833
|
|
21.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: P100, NCT01185470
|
|
22.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: CA151445, R01CA151445, NCT01281904
|
|
23.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 10-1056, NCT01269918
|
|
24.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 201106336, NCT01446874
|
|
25.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: Any Age Sponsor: Pharmaceutical / Industry Protocol IDs: CDX-353-002, NCT01660633
|